Health

Regulator paves way for NHS e-cigarettes prescriptions in England

Regulator paves way for NHS e-cigarette prescriptions in England

E-cigarettes may soon be prescribed on the NHS to help smokers quit under radical plans by ministers to slash smoking rates in England.

The Medicines and Healthcare products Regulatory Agency (MHRA) has published updated guidance that paves the way for medicinally licensed e-cigarette products to be prescribed for tobacco smokers who want to stop smoking and switch to vaping instead.

The move could see England become the first country in the world to prescribe medicinally licensed e-cigarettes. Almost 64,000 people die from smoking every year. About 3.6 million, or 7% of adults in Britain, are thought to use e-cigarettes.

Doctors, medical leaders and health campaigners welcomed the move. “I am convinced this will be a gamechanger,” said Sir Norman Lamb, the former health minister who chaired the Commons science and technology committee’s inquiry into e-cigarettes in 2018. His committee concluded that there would be “significant benefit” to having medicinally licensed e-cigarettes that could be prescribed, he said.

Prof Linda Bauld, the Bruce and John Usher chair in public health at the University of Edinburgh, said it was “excellent news”.

“While there is good evidence that e-cigarettes available as consumer products can help smokers to quit, we also know that up to one in three smokers in the UK has not tried these devices,” she said.

“Smokers have concerns about safety and misperceptions about the relative risks of e-cigarettes compared with tobacco. For some, cost is also perceived as a barrier. The option of having approved devices that could be prescribed would reassure smokers about relative risks and also assist in reaching those least able to afford e-cigarettes.”

E-cigarettes contain nicotine and are not risk-free. “The liquid and vapour contain some potentially harmful chemicals also found in cigarette smoke,” the NHS says – though these chemicals are found at much lower levels in e-cigarettes.

Public health experts have also raised concerns about young people in particular becoming hooked on vaping despite never having smoked. Tobacco companies have turned to creating the devices.

However, expert reviews have concluded that regulated e-cigarettes are less harmful than smoking. A medicinally licensed e-cigarette would have to pass even more rigorous safety checks, the Department of Health and Social Care said.

Manufacturers can now approach the MHRA and submit their products to the same regulatory approvals process as other medicines available on the NHS. If an e-cigarette gets MHRA approval, doctors could then decide on a case-by-case basis whether it would be appropriate to prescribe an e-cigarette to a patient to help them quit smoking.

Dr June Raine, the chief executive of the MHRA, said the evidence was “clear” that e-cigarettes are less harmful to health than smoking tobacco and that e-cigarettes can help people quit smoking for good. “The updated guidance on licensing requirements we have published today is a strong first step towards availability of safe and effective licensed e-cigarette products.”

The NHS said the National Institute for Health and Care Excellence (Nice) would have to give the green light to e-cigarettes before they could be rolled out on the health service. A spokesperson added: “The NHS will not be prescribing e-cigarettes unless Nice recommends them for use.”

Smoking remains the leading preventable cause of premature death. While rates are at record low levels in the UK, there are still about 6.1 million smokers in England. There are also alarming differences in rates across the country, with smoking rates in Blackpool (23.4%) and Kingston upon Hull (22.2%) vastly higher than rates in wealthier areas such as Richmond upon Thames (8%).

E-cigarettes were the most popular aid used by smokers trying to quit in England in 2020. The number of e-cigarette users grew from about 700,000 in 2012 to 3.6 million in 2019, falling to 3.2 million in 2020 before rising again in 2021 to 3.6 million.

Sajid Javid, the health secretary, said: “Opening the door to a licensed e-cigarette prescribed on the NHS has the potential to tackle the stark disparities in smoking rates across the country, helping people stop smoking wherever they live and whatever their background.”

Health

NCDC records 832 Lassa fever, Mpox cases, 135 deaths

The Nigeria Centre for Disease Control and Prevention (NCDC) has confirmed the country has recorded 832 confirmed cases of Lassa fever and Mpox.

Speaking during a press briefing on Friday in Abuja, the agency’s Director General, Dr. Jide Idris, revealed that 132 fatalities were recorded from Lassa fever and three from Mpox.

While acknowledging a recent decline in Lassa fever infections during epidemiological week 16 (ending April 20, 2025), he warned that the overall risk remains high, particularly in endemic regions.

“Cumulatively, as of week 16, Nigeria has reported 4,253 suspected cases of Lassa fever, 696 confirmed cases, and 132 deaths, resulting in a case fatality rate of 19.0 percent,” he stated.

Dr. Idris attributed recent improvements to intensified surveillance, treatment efforts, and enhanced community engagement. He emphasized, however, the continued need for vigilance and collaboration to sustain progress.

Regarding Mpox, the NCDC boss disclosed that three deaths have been recorded in 2025—two in Abia and Ebonyi States in week 10, and one recently in Rivers State involving a patient co-infected with HIV and tuberculosis. As of week 16, 723 suspected cases and 136 laboratory-confirmed cases of Mpox have been reported across 35 states and the Federal Capital Territory (FCT). The national case fatality rate currently stands at 2.2 per cent.

“The epidemic curve reveals multiple peaks in Mpox cases, indicating ongoing transmission. While most states have reported suspected cases, confirmed infections are heavily concentrated in Nigeria’s southern and central regions,” Dr. Idris noted.

To address these outbreaks, the NCDC has activated its Emergency Operations Centre (EOC), deployed National Rapid Response Teams to affected states, and prepositioned essential medical supplies, including personal protective equipment and laboratory consumables. Five additional Mpox diagnostic laboratories have also been optimized in Bauchi, Kano, Cross River, Rivers, and Enugu States.

“Healthcare workers are undergoing specialized training in infection prevention, case management, and cerebrospinal meningitis (CSM) care. Community outreach is being reinforced through public awareness campaigns, media engagement, and targeted health communication strategies,” he added.

On cerebrospinal meningitis, Dr. Idris reported a consistent decline in new cases and fatalities over the last three weeks.

He attributed the improvement to effective vaccination, early treatment, and adaptive surveillance strategies tailored to real-time data.

“Although the situation remains serious, strong national and state-level coordination is showing positive results. The response will continue until full containment is achieved and states take full ownership of the CSM Incident Action Plan,” he said.

Dr. Idris also expressed concern about the rising Mpox trend since its reemergence in 2017, with significant spikes recorded between 2022 and 2024, positioning Nigeria among the most affected countries globally. He warned that underreporting and delayed data entry remain challenges that need urgent resolution to ensure accurate and timely outbreak response.

A national mortality review for the recent Mpox deaths is being planned to further assess response effectiveness and identify areas for improvement.

The NCDC reaffirmed its commitment to safeguarding public health through timely surveillance, transparent reporting, and coordinated national response mechanisms aimed at reducing disease burden and preventing future outbreaks.

Health

Only 89 doctors left in Kwara Govt hospitals amid ‘Japa’ crisis – Health Board

The Executive Secretary of the Kwara State Hospital Management Board, Abdulrahman Malik, disclosed that there is an acute shortage of medical doctors in the state-owned hospitals.

Speaking at the state interministerial press briefing for the first quarter of 2025 on Tuesday, April 29, Malik said that due to the ‘Japa’ syndrome, doctors do not want to take up appointments with the state government, even when the government is ready to recruit them.

He lamented that while between 180 and 200 doctors are required in the government service, only 89 of them are available in the service.

He said the number of available doctors only recently became 89 from 86 when three who had left the service returned after the government introduced a new and improved salary for the doctors’ services.

The hospital board’s boss said the government had been trying to attract doctors to the state service with improved salaries and facilities that could encourage them to stay, especially in the rural areas where many of them do not want to go.

He also disclosed that the government has introduced an intern nurses programme for the training of nurses who would replace many nurses who had left the service for abroad.

“The mass exodus of health professionals is severely affecting our capacity to provide adequate care,” the official said.

“Gov. AbdulRahman AbdulRazaq has approved an upgrade in the salaries of our doctors to match federal pay in a bid to retain the few we have left.

“The revised salary structure has led to the return of three doctors who had previously resigned, bringing the total number on the state’s payroll to 89.

“However, the figure still falls short of the estimated 180 to 200 physicians needed to serve the state’s population effectively.

“Nigeria’s doctor-to-patient ratio is currently estimated at one doctor to over 5,000 patients, far below the World Health Organisation’s (WHO) recommended one doctor to 600 patients.”

Health

Wike approves recruitment of 34 resident doctors for FCT hospitals

The Minister of the Federal Capital Territory (FCT), Mr Nyesom Wike, has approved the recruitment of 34 resident doctors for a seven-year residency training to enhance health-care delivery in FCT.

Mr Lere Olayinka, Senior Special Assistant to the minister on Public Communications and Social Media, made this known in a statement in Abuja on Wednesday.

Olayinka explained that the 34 doctors would be the first batch of 60 medical doctors approved for residency training in eight specialities in FCT Administration hospitals.

He said that five out of the 34 doctors would work in the psychiatric department, four in internal medicine and one in general surgery.

Others, he said would comprise one in anesthesiology, eight in family medicine, six in ophthalmology and nine in obstetrics and gynaecology.

“This is the first time this is being done outside employees of the Health Management Board, thereby, giving doctors more opportunity and bringing more competent hands into healthcare delivery in the FCT,” he said.

The spokesman added that the remaining 26 doctors would be recruited in due course by the FCTA Civil Service Commission.

He said that the 26 doctors would comprise one for psychiatry department, four for internal medicine, eight for general surgery, five in anesthesiology, and eight paediatrics.